Keybanc Upgrades Maravai LifeSciences to Overweight, Announces $11 Price Target

Benzinga · 5d ago
Keybanc analyst Paul Knight upgrades Maravai LifeSciences (NASDAQ:MRVI) from Sector Weight to Overweight and announces $11 price target.